Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Authors :: Xuan Wei
Juanjuan Shi
Qianhan Lin
Xiaoxue Ma
Yingxin Pang
Hongluan Mao
Rui Li
Wei Lu
Yu Wang
Peishu Liu
Source :: Frontiers in Oncology, Frontiers in Oncology, Vol 11 (2021)
Publication Year :: 2021
Publisher :: Frontiers Media SA, 2021.

Subjects :: Cancer Research
ovarian cancer
Oncology
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Correction
ACLY
cisplatin resistance
PI3K-AKT pathway
AMPK-ROS pathway
RC254-282

Full Text Access

Tools